Y. Saikawa et al., COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C AND CISPLATIN FOR ADVANCED GASTRIC-CANCER WITH MULTIPLE LIVER METASTASES, SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 24(9), 1994, pp. 819-822
A patient with advanced gastric cancer with multiple liver metastases
was treated by reduction surgery at the Primary site as well as by the
intraarterial administration of mitomycin C (MMC) and cisplatin (CDDP
) through a reservoir catheter inserted into the proper hepatic artery
. After a palliative subtotal gastrectomy, MMC 8 mg/m2 was administere
d intraarterially (i.a.) followed by the administration of CDDP 80 or
40 mg/m2 i.a. with an interval of less than 1 week. After the completi
on of five courses of this regimen, a complete reduction of the hepati
c tumors was achieved, while the level of serum carcinoembryonic antig
en decreased to the normal range. The patient is currently alive with
signs of disease recurrence at 17 months after initial diagnosis, whil
e additional therapy with MMC + CDDP was continuously undergone until
17 months' after initial diagnosis with various interval. Although thr
ombocytopenia occurred during the treatment, it resolved within a few
weeks after completing the combination chemotherapy without any specif
ic treatment. The present case showed a better prognosis than we had e
xpected, which suggested that combination chemotherapy with MMC and CD
DP might thus be clinically useful because of its excellent antitumor
activity and low toxicity.